Loading...

Prelude Therapeutics Incorporated

PRLD•NASDAQ
HealthcareBiotechnology
$0.78
$-0.04(-4.49%)

Prelude Therapeutics Incorporated (PRLD) AI-Powered Stock Analysis

See how Prelude Therapeutics Incorporated scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Prelude Therapeutics Incorporated (PRLD) Stock Overall Grade

Prelude Therapeutics Incorporated’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

B

Good

Grade Breakdown by Metric

See how each financial and market factor contributes to Prelude Therapeutics Incorporated's overall stock rating.

Forecast

B

Score

64/100

Financial Growth

C

Score

40/100

Fundamental Growth

C

Score

41/100

Key Ratios

C+

Score

55/100

Sector Comparison

B+

Score

75/100

Industry Comparison

B+

Score

75/100

S&P 500 Benchmark

A

Score

85/100

Analyst Consensus

C+

Score

50/100

Component Analysis Explained

Understand the key factors behind each Prelude Therapeutics Incorporated stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal

Resources

Market

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.